Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BAUSCH AND LOMB INC

  • FDA Approval
  • Aug. 08, 2024, 08:43 UTC
  • 61
  • 0 comments

FDA approve OLOPATADINE HYDROCHLORIDE

Comment Full text

NOVUGEN

  • FDA Approval
  • Aug. 08, 2024, 08:43 UTC
  • 45
  • 0 comments

FDA approve TRAMETINIB DIMETHYL SULFOXIDE

Comment Full text

RB HLTH

  • FDA Approval
  • Aug. 08, 2024, 08:43 UTC
  • 60
  • 0 comments

FDA approve DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN

Comment Full text

ASTRAZENECA AB

  • FDA Approval
  • Aug. 08, 2024, 08:43 UTC
  • 56
  • 0 comments

FDA approve ANIFROLUMAB-FNIA

Comment Full text

AMGEN INC

  • FDA Approval
  • Aug. 08, 2024, 08:43 UTC
  • 58
  • 0 comments

FDA approve ERENUMAB-AOOE

Comment Full text

MSN

  • FDA Approval
  • Aug. 08, 2024, 04:21 UTC
  • 61
  • 0 comments

FDA approve FAMOTIDINE

Comment Full text

TEVA PHARMS INC

  • FDA Approval
  • Aug. 08, 2024, 02:24 UTC
  • 65
  • 0 comments

FDA approve AZILSARTAN MEDOXOMIL;CHLORTHALIDONE

Comment Full text

PURDUE PHARMA LP

  • FDA Approval
  • Aug. 07, 2024, 22:39 UTC
  • 60
  • 0 comments

FDA approve NALMEFENE

Comment Full text

MACLEODS PHARMS LTD

  • FDA Approval
  • Aug. 07, 2024, 15:23 UTC
  • 60
  • 0 comments

FDA approve CANAGLIFLOZIN

Comment Full text

WATSON LABS INC

  • FDA Approval
  • Aug. 07, 2024, 09:01 UTC
  • 56
  • 0 comments

FDA approve EZETIMIBE

Comment Full text
  • Previous
  • 381
  • 382
  • 383
  • 384
  • 385
  • Next

Search

News categories

  • Technical Exchange News(14659)
  • Event(6229)
  • SEC News(390823)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(238635)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin